I love Math&Stats, particularly Biostats, ExtremeValueTheory, Bayesian Statistics, Stochastic Processes AND the Alps and all kind of sports you can do there
Nicht veräppeln lassen: der "Strippenzieher der WerteUnion" Markus Krall verbreitet Klimaleugner-Lügen. Dieser Eisbohrkern aus Grönland von Richard Alley endet im 19. Jh, vor Beginn der modernen Erderwärmung. Alley hat sich längst in der NYTimes gegen diesen Fake gewehrt. 🧵1/4
Pleased to announce 7th @EFSPItweet Regulatory Statistics Workshop!
Date: Sep 14 – 15, 2022.
Type: hybrid, focus on in-person attendance at @biozentrum in Basel.
Line-up: speakers from several EU Health Authorities, FDA, PMDA, academia and industry.
1/n
We are looking for a new biostatistician to join our BioStats team at @PEI_Germany. Interested? Just drop me a message. More details here:
https://t.co/LOOvzVXyeV
@BenjaminHofner
@statberry and @kertviele will be speaking at the @imi_eupearl webinar on non-concurrent controls in platform trials on 2/24/22. They and others will discuss with external stakeholders when and how to utilise non-concurrent control data in platform trials. https://t.co/UbGUAjCgOS
🤔 Are you interested in the topic of non-concurrent controls in #clinicaltrials?
Discover when and how you can incorporate them in #platformtrials in our interactive #webinar conducted by statistical experts
🔗https://t.co/TALYsUXMPX
Join the BioStats team at PEI! In the context of a third-party funded project on the applicability of artificial intelligence (AI) in the regulatory field, we are looking for a new colleague. Questions ? Just drop me a message. https://t.co/UupZvjwa23
@PEI_Germany @BenjaminHofner
📢SAVE THE DATE!
Webinar on the use of the non-concurrent controls in platform trials:
🗓️24 February 2022
⌚️(4-7 PM CET).
✍️Registration open at: https://t.co/TSfsx0QdEK
#biostatistics#clinicalresearch
We are looking for a PhD student in the field of biostatistics. The PhD project is intended to contribute to a better understanding of novel clinical trial designs, so-called platform trials. For further information:
https://t.co/lTDo2yE6Ub
@BenjaminHofner @PEI_Germany
Annette Baker, president of @ChildrensTumor and member of @imi_eupearl explains in @FortuneMagazine how COVID-19 could change clinical trials for the better. @imi_eupearl will bring this framework of platform trials to test multiple drugs simultaneously. https://t.co/PSXwyXDdSX
Dieses Diagramm wird grade gerne geteilt. @ManuelaSchwesig benutzt es, @johannesboie , @politicalbeauty und noch ein paar mehr. Und vielen gefällt das.
Aussage: Deutschland ist ganz schlecht beim Impfen, einige sagen sogar "Letzter". Shame on you, @jensspahn!
Warum läuft das Impfen in Deutschland und EU so langsam an? Hat die EU bei der Impfstoff-Bestellung versagt?
Nicht alles ist optimal gelaufen, aber die Alternativen waren schlechter.
Ein Thread 👇
Our article (with @strakaps) about #bursty extremes is out, modeling extremes with heavy-tailed inter-arrival times. It's available for free until December 12 via https://t.co/ukJxUIOY1j
@NayelBettache@GillesStupfler Initially, it was not our plan to do that. But we will ask every speaker shortly before the beginning of their talk whether or not they agree to that. I will let you know :-)
Interested in statistics of extremes, extreme weather events, or change-points? Join our virtual workshop on "Change-points and Extremes in Space and Time" tomorrow via Zoom! More information at https://t.co/hGMZ1twjYp
@GillesStupfler